Large-scale Denosumab-Study shows: Fracture Rate in postmenopausal Women with Osteoporosis is significantly reduced by the use of Denosumab

被引：0
|
作者：
Resch, H. [1 ]
机构：
[1] Krankenhaus Barmherzigen Schwestern, Stumpergasse 13, A-1060 Vienna, Austria
来源：
JOURNAL FUR MINERALSTOFFWECHSEL | 2010年 / 17卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [1] Denosumab: A Review of its Use in Postmenopausal Women with Osteoporosis
    Scott, Lesley J.
    DRUGS & AGING, 2014, 31 (07) : 555 - 576
  • [2] Denosumab: A Review of its Use in Postmenopausal Women with Osteoporosis
    Lesley J. Scott
    Drugs & Aging, 2014, 31 : 555 - 576
  • [3] DENOSUMAB REDUCED OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WITH PRIOR FRACTURE: RESULTS FROM FREEDOM
    Palacios, Santiago
    Rizzoli, R.
    Zapalowski, C.
    Resch, H.
    Adami, S.
    Adachi, J. D.
    Gallagher, J. C.
    Feldman, R. G.
    Kendler, D. L.
    El-Haschimi, K.
    Wang, A.
    Wagman, R. B.
    Boonen, S.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S299 - S300
  • [4] Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis
    Palacios, S.
    Kalouche-Khalil, L.
    Rizzoli, R.
    Zapalowski, C.
    Resch, H.
    Adachi, J. D.
    Gallagher, J. C.
    Feldman, R. G.
    Kendler, D. L.
    Wang, A.
    Wagman, R. B.
    Adami, S.
    CLIMACTERIC, 2015, 18 (06) : 805 - 812
  • [5] VALIDATION OF A BUDGET IMPACT MODEL FOR USE OF DENOSUMAB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Mehta, D.
    Stolshek, B.
    Agodoa, I
    VALUE IN HEALTH, 2015, 18 (03) : A157 - A157
  • [6] FREEDOM TRIAL: DENOSUMAB IS NOT ASSOCIATED WITH FRACTURE HEALING COMPLICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Adami, Silvano
    Palacios, Santiago
    Pavelka, Karel
    Resch, Heinrich
    Roux, Christian
    Uebelhart, Daniel
    Ho, Pei-Ran
    Wang, Andrea
    Siris, Ethel
    Libanati, Cesar
    Adachi, Jonathan
    Boonen, Steven
    Cummings, Steven
    de Gregorio, Luiz
    Gilchrist, Nigel
    Lyritis, George
    Moeller, Gerd
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 243 - 244
  • [7] TRABECULAR BONE SCORE (TBS) IS SIGNIFICANTLY IMPROVED BY DENOSUMAB (DMAB) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
    Brandi, Maria Luisa
    Lippuner, Kurt
    Kaufman, Jean-Marc
    Mcclung, Michael R.
    Zachetta, Jose R.
    Krieg, Marc-Antoine
    Bone, Henry G.
    Chapurlat, Roland
    Hans, Didier
    Wang, Andrea
    Yun, Jang
    Zapalowski, Carol
    Libanati, Cesar
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S204 - S204
  • [8] Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
    Lai, E. C-C
    Lin, T-C
    Lange, J. L.
    Chen, L.
    Wong, I. C. K.
    Sing, C-W
    Cheung, C-L
    Shao, S-C
    Yang, Y-H Kao
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 1155 - 1164
  • [9] Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
    E. C.-C. Lai
    T.-C. Lin
    J. L. Lange
    L. Chen
    I. C. K. Wong
    C.-W. Sing
    C.-L. Cheung
    S.-C. Shao
    Y.-H. Kao Yang
    Osteoporosis International, 2022, 33 : 1155 - 1164
  • [10] The Transition from Denosumab to Teriparatide or from Teriparatide to Denosumab in Postmenopausal Women with Osteoporosis: The DATA-Switch Study.
    Leder, Benjamin
    Tsai, Joy
    Uihlein, Alexander
    Zhu, Yuli
    Foley, Katelyn
    Neer, Robert
    Burnett-Bowie, Sherri-Ann
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S52 - S52
12345